FDA Inspection 1148287 — CAIRE DIAGNOSTICS INC

CAIRE DIAGNOSTICS INC — FEI 3013216353

The FDA completed an inspection of CAIRE DIAGNOSTICS INC on Aug 3, 2021 in Pleasanton, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 3, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Pleasanton, CA (United States)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.